Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breast Carcinoma
|
2793 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.740 | 0.800 | 5 | 2016 | 2018 | |||||
Glioblastoma
|
281 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.040 | 1.000 | 4 | 2015 | 2017 | |||||
Malignant neoplasm of breast
|
3417 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.040 | 0.750 | 4 | 2016 | 2018 | |||||
Malignant Neoplasms
|
1641 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.040 | 1.000 | 4 | 2015 | 2018 | |||||
Primary malignant neoplasm
|
1374 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.040 | 0.750 | 4 | 2015 | 2018 | |||||
Carcinoma of lung
|
1204 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.030 | 1.000 | 3 | 2013 | 2018 | |||||
Malignant neoplasm of lung
|
1142 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.030 | 1.000 | 3 | 2013 | 2018 | |||||
Neoplasms
|
1644 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.030 | 1.000 | 3 | 2015 | 2015 | |||||
Primary malignant neoplasm of lung
|
981 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.030 | 1.000 | 3 | 2013 | 2018 | |||||
Malignant neoplasm of stomach
|
615 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.020 | 1.000 | 2 | 2016 | 2017 | |||||
Stomach Carcinoma
|
652 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.020 | 1.000 | 2 | 2016 | 2017 | |||||
Acute monocytic leukemia
|
22 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Adenocarcinoma
|
168 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Adult Glioblastoma
|
98 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Adult Liver Carcinoma
|
72 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Childhood Glioblastoma
|
98 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Colorectal Carcinoma
|
1962 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.010 | 1 | 2015 | 2015 | ||||||
Diabetes Mellitus
|
824 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Ependymoma
|
8 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Glioblastoma Multiforme
|
186 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Ichthyosis, X-Linked
|
10 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Leukemia, Myelocytic, Acute
|
6892 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Liver and Intrahepatic Biliary Tract Carcinoma
|
73 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Liver carcinoma
|
942 | 0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 | 0.010 | 1.000 | 1 | 2016 | 2016 |